$20.69
▼ $-0.97
(-4.48%)
Vol 174K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$319.1M
ROE
-14.1%
D/E
0.01
Beta
1.58
52W
$7–$37
Wall Street Consensus
14 analysts · Apr 20265
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating
Price Chart
Similar Stocks
DMAC
DiaMedica Therapeutics Inc
$414.5M
CABA
Cabaletta Bio Inc
$210.8M
XOMA
Xoma Royalty Corp
P/E 15.2
$329.3M
IRD
Opus Genetics Inc
$138.6M
XFOR
X4 Pharmaceuticals Inc
$349.7M
FBRX
Forte Biosciences Inc
$341.6M
SRZN
Surrozen Inc
$193.7M
GLSI
Greenwich Lifesciences Inc
$291.1M
PALI
Palisade Bio Inc
$350.2M
CLYM
Climb Bio Inc
$272.7M
Earnings
Beat rate: 100.0%
Next Report
May 07, 2026
EPS Estimate: $-1.26
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.26 | — | — |
| Dec 2025 | $-1.21 | $-1.17 | +$0.04 |
| Sep 2025 | $-1.28 | $-0.99 | +$0.29 |
| Jun 2025 | $-1.18 | $-1.05 | +$0.13 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -38.9% | -38.9% | -38.9% | -38.9% | -14.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| Current Ratio | 18.07 | 18.07 | 18.07 | 18.07 | 18.07 | 18.39 |
Key Ratios
ROA (TTM)
-13.0%
P/B
1.1
EPS (TTM)
$-1.99
52W High
$37.27
52W Low
$6.88
$6.88
52-Week Range
$37.27
How does NGNE compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
NGNE valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼
56%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
NGNE profitability vs Biotechnology peers
ROE
-14.1%
▲
79%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-13.0%
▲
72%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
NGNE financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
18.4
▲
314%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.6
▲
63%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
NGNE fundamentals radar
NGNE
Peer median
Industry
NGNE profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NGNE vs peers: key metrics
Latest News
No related news yet